Sapiens International (SPNS) has had the highest return since January 1, 2025 by a US stock with a market cap of $1,998+, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 14,727.84% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,487.57% |
NovaBay Pharmaceuticals (NBY) | 1,258.97% |
Diginex Limited Ordinary Shares (DGNX) | 1,210.8% |
FiEE (FIEE) | 1,156.88% |
Oncology Institute (TOI) | 1,043.79% |
Zepp Health (ZEPP) | 967.69% |
Palvella Therapeutics (PVLA) | 759% |
Relmada Therapeutics (RLMD) | 738.47% |
Abits (ABTS) | 732.29% |
Cidara Therapeutics (CDTX) | 714.46% |
DeFi Development (DFDV) | 665.34% |
Celcuity LLC (CELC) | 665.2% |
Hycroft Mining (HYMC) | 626.55% |
Nanobiotix (NBTX) | 611.58% |
Terns Pharmaceuticals (TERN) | 607.45% |
Avino Silver & Gold Mines (ASM) | 605.49% |
TMC the metals (TMC) | 592.11% |
DBV Technologies (DBVT) | 591.79% |
Lizhi (SOGP) | 590.55% |
Newegg Commerce (NEGG) | 579.38% |
Sandisk (SNDK) | 577.72% |
AXT (AXTI) | 559.91% |
